Health Care Utilization and Costs Associated With Systemic First-Line Metastatic Melanoma Therapies in the United States.

PURPOSE:US Food and Drug Administration approvals of immune checkpoint inhibitors and targeted therapies revolutionized the treatment of metastatic melanoma. Our aim was to assess health care resou...